Sec. 330. Interagency body on research related to per- and polyfluoroalkyl substances
593 words·~3 min read·
/bill/116/hr/6395/rh/section-330·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Director of the Office of Science and Technology Policy, acting through the National Science and Technology Council, shall establish an interagency working group to coordinate Federal activities to advance research and development needed to address PFAS. The interagency working group shall include a representative of each— the Environmental Protection Agency; the National Institute of Environmental Health Sciences; the Agency for Toxic Substances and Disease Registry; the National Science Foundation; the Department of Defense; the National Institutes of Health; the National Institute of Standards and Technology; the National Oceanic and Atmospheric Administration; the Department of Interior; the Department of Transportation; the Department of Homeland Security; the National Aeronautics and Space Administration; the National Toxicology Program; the Department of Agriculture; the Geological Survey; the Department of Commerce; the Department of Energy; the Office of Information and Regulatory Affairs; the Office of Management and Budget; and any such other Federal department or agency as the President considers appropriate.
The Interagency working group shall be co-chaired by the Director of the Office of Science and Technology Policy and, on an annual rotating basis, a representative from a Member agency, as selected by the Director of the Office of Science and Technology Policy. The interagency working group established under subsection
(a)shall— provide for interagency coordination of Federally funded PFAS research and development; and not later than 12 months after the date of enactment of this Act, develop a strategic plan for Federal support for PFAS research and development (to be updated not less than every 2 years) that— identifies all current Federally funded PFAS research and development, including the nature and scope of such research and development and the amount of funding associated with such research and development during the current fiscal year, disaggregated by agency; identifies scientific and technological challenges that must be addressed to understand and to significantly reduce the environmental and human health impacts of PFAS and to identify cost-effective— alternatives to PFAS that are designed to be safer and more environmentally friendly; methods for removal of PFAS from the environment; and methods to safely destroy or degrade PFAS; establishes goals, priorities, and metrics for Federally funded PFAS research and development that takes into account the current state of research and development identified in paragraph
(A)and the challenges identified in paragraph (B); and an implementation plan for Federal agencies. In developing the strategic plan under subsection (d), the interagency working group shall consult with states, tribes, territories, local governments, appropriate industries, academic institutions and nongovernmental organizations with expertise in PFAS research and development, treatment, management, and alternative development. For each fiscal year beginning with fiscal year 2022, not later than 90 days after submission of the President’s annual budget request for such fiscal year, the Interagency working group shall prepare and submit to Congress a report that includes— a summary of Federally funded PFAS research and development for such fiscal year and the preceding fiscal year, including a disaggregation of spending for each participating Federal agency; and a description of how Federal agencies are implementing the strategic plan described in subsection (d). The term PFAS research and development includes any research or project that has the goal of accomplishing the following: The removal of PFAS from the environment. The safe destruction or degradation of PFAS. The development and deployment of safer and more environmentally friendly alternative substances that are functionally similar to those made with PFAS. The understanding of sources of environmental PFAS contamination and pathways to exposure for the public. The understanding of the toxicity of PFAS to humans and animals.